Candel Therapeutics CADL
NASDAQ CADL
$10.16 -0.28 (-2.68%)
At close: Oct 1, 2026 · 4:00 PM EDT

Candel Therapeutics (CADL) Treasury Shares (2023 - 2026)

Updated

Candel Therapeutics' Treasury Shares came in at $448,000 for Q2 2026, unchanged from $448,000 a year earlier.

Analysis

Candel Therapeutics (CADL) Treasury Shares (2023 - 2026) Analysis & Trends

Going back to Q2 2022, Candel Therapeutics' Treasury Shares data covers 16 quarters.

  • Treasury Shares carries a three-year compound annual growth rate of 0.0% (FY2022 to FY2025).
  • Going back by year, Treasury Shares was $448,000 in FY2024 (unchanged), $448,000 in FY2023 (unchanged) and $448,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 711.62 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 77.11 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.11 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -49.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Candel Therapeutics 794.67 Mn 794.67 Mn - -122,608.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -122,608.00
Dec 31, 2025 -122,608.00
Sep 30, 2025 -122,608.00
Jun 30, 2025 -122,608.00
Mar 31, 2025 -122,608.00
Dec 31, 2024 -122,608.00
Sep 30, 2024 -122,608.00
Jun 30, 2024 -122,608.00
Mar 31, 2024 -122,608.00
Dec 31, 2023 -122,608.00
API Access

Candel Therapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=CADL&period=max&api_key=YOUR_API_KEY